Oxford Properties Group (“Oxford”), a leading global real estate investor, asset manager and business builder, and Novaxia, a premier French urban developer, (“the Partnership”) has completed the acquisition of the Biocitech life sciences campus in Paris, France. The deal marks the first acquisition of the Partnership, announced in May this year, to invest approximately €1 billion to acquire and develop life sciences buildings across France.
Biocitech, located in the Romainville submarket of Paris, comprises 21,000 square metres of lab, office and specialist storage space across seven buildings and enjoys a rich history as a life sciences hub. The campus is leased to 17 occupants including Galapagos, Mutabilis and Nextdot. Two-thirds of the occupiers are mature companies with the remaining third start-ups, creating a scientific community with endeavours across biotechnology, biopharmaceuticals, bioinformatics, the provision of scientific and technological services as well as medical devices and equipment.
Source: oxfordproperties.com the 17th of November 2022
https://www.oxfordproperties.com/news/oxford-and-novaxia-partner-for-its-first-french-life-sciences-acquisition